This Vaccine Stock Soars 47% After $1.1 Billion AstraZeneca Deal

Icosavax stock soared 47% in Tuesday premarket trading after the Seattle-based vaccine developer reached a deal to be acquired by pharmaceutical giant AstraZeneca.

#seattle #astrazeneca